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Abstract
Background
Gamma knife radiosurgery (GKRS) remains a critical intervention in the long-term
management of arteriovenous malformations (AVMs). For planning a treatment, identification
of the nidus is essential, and it is dependent on high-resolution blood flow imaging, usually in
the form of a traditional angiogram. The development of dynamic 320-slice computed
tomography (CT) angiography has offered a noninvasive alternative to intra-arterial
fluoroscopic imaging, and it is capable of providing equivalent temporal resolution. In this
study, we describe the feasibility of using four-dimensional CT angiography (4D-CTA) in GKRS
planning for AVM treatment and a comparative analysis with a traditional angiogram.
Methods
A retrospective review was performed on AVM patients treated via GKRS with a 4D-CTA prior
to the day of treatment, on the day of treatment, or with a day-of-treatment angiogram.
Treatment times, along with total times in the Leksell® coordinate frame G, were obtained from
the medical records. The frame-on time was calculated by subtracting the treatment time from
the total time starting from application to removal, and the statistical analysis was performed
across groups using analysis of variance (ANOVA). All treatments were performed on the
Perfexion™ model with a dynamic flow imaging procured via a 320-slice CT scanner or
traditional angiography platform.
Results
Some 27 patients underwent a total of 29 GKRS procedures for AVM treatment at our
institution between September 2011 and January 2017. Mean age at the time of treatment was
35.5 (6-65) years, and male:female ratio was 5:4. Some 12 patients had 4D-CTA performed prior
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to the day of treatment, eight patients had the same CTA completed after frame placement on
the day of treatment, while seven patients underwent traditional angiography. The mean
frame-on times of each group were 190, 336, and 426 minutes, respectively (p < 0.0001). No
procedures were aborted based on the image quality.
Conclusions
4D-CTA is an effective tool in identifying the AVM nidus for GKRS planning. These studies can
be performed prior to the day of treatment, allowing for a significant reduction in frame-on
time and eliminating the risk of angiogram complication on the day of GKRS.
Categories: Radiation Oncology, Neurosurgery
Keywords: arteriovenous malformation, gamma knife, radiosurgery, four-dimensional cta
Introduction
The appropriate treatment of cerebral arteriovenous malformations (AVMs) has been the
subject of considerable debate over the past decade [1]. Risk stratification analysis of
unruptured versus ruptured AVMs has prompted an in-depth discussion regarding not only the
best treatment modality options, but also the primary determination to offer any form of
treatment [1-2]. Despite these controversies, gamma knife radiosurgery (GKRS) continues to
serve a critical function in the primary treatment of the newly diagnosed AVMs as well as the
residual disease following surgical intervention [3-4]. 
Paramount to the success of GKRS treatment of AVMs is precise identification and obliteration
of the nidus. The classical approach to such a treatment requires a two-dimensional (2D)
cerebral angiogram after application of the Leksell® coordinate frame G (Elekta AB, Stockholm,
Sweden), followed by a contrast-enhanced three-dimensional (3D) magnetic resonance image
(MRI). In a patient population that has already completed a diagnostic digital subtraction
angiography (DSA), this treatment-associated study is not only redundant from an imaging
perspective, but also exposes the patients to the risks of additional contrast agent, catheter port
site injury, as well as intracranial hemorrhage, albeit at historically low rates [5-6]. Modern
imaging advances, including dynamic CT angiography on 320- and 640-slice four-dimensional
(4D) scanners, offer a novel mechanism for capture of blood flow imaging with temporal
resolution rivaling fluoroscopic capture and offer a safe and effective diagnostic alternative to
traditional angiography [7]. Originally employed in cardiac imaging, the use of four-
dimensional CT angiography (4D-CTA) has evolved to encompass diagnosis of cerebral AVMs
and dural arteriovenous (AV) fistulas [8-9]. In addition, to avoid any potential DSA-associated
complications, these 4D-CTA image sets provide the AVM nidal target in a 3D space for direct
transfer into the planning software. 
In the present study, we review a single-institutional experience using 4D-dynamic volume CTA
in GKRS of AVMs as an alternative to catheter-based angiography for the day of service (DOS)
flow study used in treatment planning and identify a novel workflow for reducing the time
required for the patients to remain immobilized in the Leksell® coordinate frame G.
Materials And Methods
Study design and patient population
An IRB-approved retrospective review of the patients who received GKRS treatment for cerebral
AVMs from 2011 to 2017 was performed. All the patients had a confirmatory diagnostic flow
study (DSA, CTA) performed prior to GKRS. Spetzler-Martin grades were assigned to each AVM
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by a neuroradiologist. Three separate workflows were used for GKRS imaging and treatment
(Figure 1). 
FIGURE 1: Radiosurgery AVM treatment workflow.
Patients were treated by one of three mechanisms, with either an angiogram or 4D-CTA
performed after frame placement on the day of service (DOS angiogram, DOS CTA) or with a
CTA performed within four weeks prior to the day of treatment (pre-DOS CTA).
Two of the treatment paradigms included all DOS imaging (DSA or CTA) while the third distinct
workflow included a pre-DOS CTA performed within the preceding 30 days of treatment. 
AVM treatment imaging 
Dynamic flow imaging was performed for treatment targeting using either the Aquilion ONE
(Toshiba Corporation, Tokyo, Japan) 320-slice CT scanner or the Artis Angiography (Siemens
Healthcare, Malvern, PA) platform. The patients undergoing a 4D-CTA on the Aquilion ONE
scanner were imaged using 80-120 kV, 100-240 mAs, 320 slice × 0.5 mm collimation with
acquisition of three to four frames per second. Whole brain volumes were acquired and
reviewed by the neuroradiologist and the treatment team (neurosurgeon/radiation oncologist)
for identification of the earliest filling phase of the AVM nidus (Figure 2). 
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FIGURE 2: Time-resolved CTA (4D-CTA) for nidus identification.
A representative case of treatment planning in an 11-year-old patient using pre-DOS 4D-CTA to
identify the earliest filling phase (A) through last peak arterial phase and maximal intensity
projection (MIP) images (B and C, respectively).
For patients undergoing cerebral angiogram on the DOS, right common femoral artery access
was secured using a 5 Fr catheter via a standard Seldinger technique. The AVM visualization
was achieved following manual injection of a contrast agent and biplanar image acquisition
(two to five frames per second) on the Siemens Artis angiography system.
GKRS technique
 Leksell® coordinate frame G placement was performed with either moderate sedation or
general anesthetic. All patients were imaged with a DOS MRI/MRA and either a diagnostic
cerebral angiogram or a 4D-CTA. The digital imaging and communications in medicine
(DICOM) formatted images were uploaded to the GammaPlan® software (Elekta AB, Stockholm,
Sweden) where a conformal target representing the nidus was developed using the dynamic
flow study (Figure 3A). A volumetric noncontrast CT head was performed for skull definition
and used for image fusion with CTA when 4D-CTA was acquired (Figure 3B). Target contouring
and refinement with a gadolinium-enhanced MRI was used as a confirmation of nidus location
(Figure 3C). All treatments were completed on the Perfexion™ Gamma Knife system (Elekta AB,
Stockholm, Sweden) utilizing 4, 8, and 16 mm collimators. Frames were removed immediately
at the completion of the treatment, regardless of the level of anesthesia.
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FIGURE 3: Sequential target delineation and contouring for
GKRS treatment.
The DICOM source volume images from the earliest filling phase of the 4D-CTA are used for
contour development in GammaPlan® (A). On the day of service, the 4D-CTA, and the
associated target contour, are co-registered to the volumetric CT head (B). The postgadolinium
T1 and time of flight (TOF) MRI sequences are used for contour verification and further
refinement as needed (C).
Calculation of “in frame” time
The precise time of frame application and removal were noted in each medical record. The total
treatment beam-on time was subtracted from the total frame application time to determine the
“in frame” time for each patient, independent of the treatment length and expressed in
minutes. All cases for the treatment of AVM were treated as the first case of the day,
eliminating any excess "in frame" time that could occur when multiple patients were treated
with GKRS within the same day. 
Determination of obliteration 
The follow-up imaging was performed at regular intervals (three to six months) with a
combination of CTA, MRA, or a catheter angiogram. The time to obliteration (TTO) was
determined by calculating from the DOS of GKRS to the date of the first imaging study
demonstrating absence of fistulous flow. Formal angiograms were used as the gold-standard
confirmatory examination. In cases where the preceding CTA or MRA appeared to demonstrate
obliteration and this was subsequently by a catheter angiogram, the date of the preceding test
was used for calculation.
Statistical analysis
Data are expressed as mean and standard error of the mean for the continuous variables of age,
target volume, maximal dose, margin dose, and “in frame” time. Statistical significance was
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determined via one-way analysis of variance (ANOVA) with multiple comparisons with post-
hoc analysis (Fisher’s LSD) using GraphPad Prisim V6.07 (GraphPad Software Inc, LaJolla, CA).
Statistical significance was determined at the level of p < 0.05.
Results
Patient demographics and radiosurgical treatment parameters
Some 27 patients underwent a total of 29 GKRS procedures for AVM treatment at our
institution between September 2011 and January 2017. Mean age at the time of treatment was
35.5 (6-65) years, and the overall male:female ratio was 5:4. Spetzler-Martin grades ranged
from I to V. Analysis performed on the subsets of patients according to the three treatment
workflow groups is summarized in Table 1. No statistically significant differences were noted
amongst these groups (p > 0.05). The maximal dose received across all the patient workflow
categories ranged from 32.1 to 47 Gy, while the mean margin doses ranged from 16 to 23 Gy
with all prescriptions at the 50% isodose line, both without any significant differences across
the workflow categories (Table 1).
 Pre-DOS CTA DOS CTA DOS Angiogram p
Patient demographics N = 12 N = 8 N = 7  
Mean age (years) 32.4 (11-55) 43.1 (17-63) 27.4 (6-65) 0.16
Gender (M:F) 2:1 1:1 3:4 0.591
Target volume (cm3) 4.65 ± 1.39 7.25 ± 1.89 6.54 ± 1.90 0.867
Spetzler-Martin grade II-7; III-3; IV-2 I-1; II-3; III-2; IV-2 I-1; II-1; III-3; IV-1; V-1 0.176
Treatment parameters     
Maximal dose (Gy) 37.2 (32.1-40.5) 39.2 (36.1-44.9) 38.1 (32.2-47.0) 0.503
Margin dose (Gy) 18.5 (16-20) 19.3 (18-22) 18.9 (16-23) 0.674
Frame time (minutes) 190 ± 13.5 336 ± 31.3 426 ± 37.8 <0.0001
TABLE 1: Patient demographics and GKRS treatment data.
No significant differences were seen in the patient or AVM characteristics across each different workflow group based on ANOVA.
The only significant difference (p < 0.0001) was seen in the calculated "in-frame" time, consisting of the total frame time minus the
beam-on treatment time.
 Reduction of “in frame” time
The AVM patients treated with a GKRS using a pre-DOS CTA for the identification of the nidal
target had a significant reduction of “in frame” time (190 ± 13.5 minutes) compared to a DOS
angiogram (426 ± 37.8 minutes; p < 0.0001) and DOS CTA (336 ± 31.3 minutes; p = 0.0016).
Furthermore, a comparison of DOS CTA and DOS angiogram did demonstrate a more modest
nonsignificant reduction of mean “in frame” time by 89.3 min (p = 0.0816) (Table 2).
2018 Cifarelli et al. Cureus 10(6): e2788. DOI 10.7759/cureus.2788 6 of 12
 Frame time (min) Mean difference (DOS Angio Ref.) p 95% CI
Pre-DOS CTA 190 ± 13.5 235 <0.0001 146-324
DOS CTA 336 ± 31.3 89.3 0.0816 -9.95-189
DOS Angiogram 426 ± 37.8 Ref. Ref.  
TABLE 2: Statistical analysis of frame times.
Using the traditional DOS angiogram approach as the reference, the mean difference in adjusted frame time was found to be
significantly less (p < 0.0001) in the group of patients with pre-DOS imaging and pre-planning.
General anesthetic time
A total of five out of the total 27 patients reviewed received general anesthesia for frame
placement and subsequent GKRS treatment, including 57% of pediatric patients. Of those
patients receiving general anesthesia, the patients in the pre-DOS CTA group had a mean “in
frame” time and general anesthetic time, of 193 ± 29 minutes while the DOS angiogram group
had an anesthetic exposure time of 261 ± 69 minutes, a difference that did not reach statistical
significance (p = 0.471).
Time to obliteration of AVM
Of the 27 patients treated with GKRS for AVM, follow-up imaging data was available for 23
patients, with 11 patients demonstrating complete obliteration. Among those with radiographic
evidence of obliteration, the time from treatment to obliteration was not significantly different
among the treatment groups, with an overall mean of 885 days (2.4 years) (Table 3).
 Mean time to obliteration (days ± SEM) n p
Pre-DOS CTA 890 ± 123 5
0.985DOS CTA 904 ± 261 3
DOS Angiogram 861 ± 86 3
TABLE 3: Time to obliteration.
Of the 23 patients with continued follow-up, a total of 11 had radiographic evidence of obliteration [angiogram (five), CTA (five), or
MRA (one)], without significant difference in the time to obliteration.
Discussion
The successful use of GKRS within a wide scope of intracranial diagnoses is directly
proportional to the precision with which the treatment dose is delivered and the accuracy of the
pre-procedural images in identification of the target. In this regard, both Perfexion™ and
ICON™ Gamma Knife systems (Elekta AB, Stockholm, Sweden) boast a QA precision check of
less than 0.4 mm, while the latter is variable across imaging modalities. The need for volumetric
data in AVM target delineation has traditionally required CT and MRI acquisition with
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correlation of the flow data from angiography [10-11]. Unfortunately, the 2D data from the DSA
is of limited use in developing the 3D plan, even with precise co-registration via the Leksell®
coordinate frame G [12]. Prior studies have attempted to determine the capacity of MR
angiography as a potential replacement for the nidal data provided by DSA. While several
studies found that medium-sized AVMs with compact niduses were adequately demarcated with
MRI/MRA only, others found greater utility in MRI as an adjunctive imaging modality
determining that DSA remained necessary for accurate targeting based on variances in plans to
known target locations [13-14].
The development of the 4D-CTA using 640-slice acquisition allows for image capture that
approaches that of biplanar fluoroscopic images, reaching 0.3-3 frames/second in comparison
to 3-10 frames/second in DSA [15-16]. Coupled with the ability to rapidly image the entire
volume of the head over 16 cm, the 4D-CTA remains a powerful diagnostic tool for a variety of
intracranial pathologies [17-18]. Our work expands that role by assessing the feasibility of
performing a high-resolution dynamic CT angiogram as an alternative to the traditional
catheter-based angiography, specifically in the context of treatment planning of GKRS for
AVMs.
Vascular imaging with temporally resolved 3D CT angiography is not a novel technique, having
been established as an effective method for cardiovascular imaging, including coronary artery
evaluation [19-20]. With regard to diagnostic cerebrovascular imaging, 4D-CTA has been shown
to be a reliable means of identification of AVMs, dural AV fistula, as well as aneurysms [18, 21-
22]. Here, we present the first series of AVM patients treated with GKRS using 4D dynamic
volume CTA angiography for nidus localization and treatment targeting, either before or after
the placement of the Leksell® Coordinate Frame G on the day of GKRS treatment. Previously,
our institution has reported a single case in which the 4D-CTA was used as a DOS study for
treatment planning, including the use of titanium frame pins, creating a significant image
artifact [23]. This artifact has been well documented by other groups utilizing only CT-based
treatment planning as an alternative to MRI [24-25]. As there is no frame present in the pre-
DOS CTA images, any artifact potentially obscuring nidus identification has been subsequently
avoided.
With the development of the ICON system, gamma knife radiosurgery has experienced its first
trend toward frameless treatment strategies, as already embraced by Linac-based
platforms [26-27]. As more patients receive treatment via this system, we are likely to see
further reduction in the need for frame-based radiosurgery, especially in large lesions already
treated with dose- or volume-fractionated SRS [28-29]. In our study, treatment remains a
frame-based procedure, but the use of the 4D-CTA as part of the planning process in advance of
frame placement demonstrates a significant reduction of “in frame” time. Although not
quantifiable, we were also provided increased time for image analyses with CTAs performed
prior to the day of service, insuring that all members of the treatment team, including the
neuroradiologists, had the opportunity to review the images and develop a consensus opinion
on the optimal target site. 
In addition to the reduction in nontreatment frame time, we examined the effect of the pre-
DOS CTA planning on the amount of general anesthetic provided during treatment. Of the 27
patients treated, only five received general anesthesia, including nearly 60% of the pediatric
AVM patients reviewed in this study. Across the treatment groups, pre-DOS CTA and DOS-
angiogram, we did find a reduction in mean general anesthetic time (193 ± 29 minutes versus
261 ± 69 minutes). Yet, these data were not significant, likely based on the limited total number
of patients (n = 5). Given the link between procedure duration and risks of anesthetic
complications in pediatric patients undergoing general anesthesia for radiotherapy cases, this
reduction in total anesthesia time may importantly reduce such risks [30]. 
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The limitations of this study begin with its single institution, retrospective nature. The limiting
factor in expanding this work on a multi-institutional basis is obviously imaging equipment
availability, recognizing that 320- and 640-slice CT scanners are not in widespread use.
Perhaps the greatest limitation of this work is the fact that has been designed as a feasibility
study only, not aimed at comparing obliteration rates, although the TTO did not vary across the
different workflows (Table 3). In Figure 4, we present a representative radiographic timeline to
obliteration over 18 months following GKRS in an 11-year-old patient who underwent the pre-
DOS CTA treatment.
FIGURE 4: Example of AVM obliteration using 4D-CTA pre-
planning technique.
A diagnostic cerebral angiogram was used for initial diagnosis and characterization of the AVM
architecture (A and B). Following GKRS, serial MRI/MRA examinations were performed every
six months until obliteration was suspected. At 18 months following GKRS, repeat angiogram
demonstrated complete obliteration of the Spetzler-Martin Grade III AVM (C and D).
Once again, angiography remained the gold standard diagnostic instrument for initial diagnosis
and confirmation of obliteration once MRI/MRA and/or CTA indicated its use. Given the natural
history of AVMs, including those treated with GKRS, we anticipate having the ability to report
the complete obliteration follow-up data in the pre-DOS CTA and DOS CTA patients as the
three-year post-treatment time frame passes. 
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This study does not support the use of 4D-CTA as a replacement imaging modality in lieu of
traditional cerebral angiography for lesion diagnosis. We recognize that the accurate
characterization of the complex architecture of the majority of AVMs often requires the use of
traditional catheter angiography, especially in higher grade Spetzler-Martin lesions. Moreover,
the test of cure in our patient population remains catheter-based angiography. Yet, despite the
continued importance of DSA in AVM management, we assert that the data support the utility
of 4D-CTA in GKRS planning for AVM and would benefit from further study. Finally, the use of
a DOS volumetric CT scan for image merging with the pre-DOS CTA may be applicable to AVMs
treated via additional SRS treatment platforms, such as CyberKnife. Unlike the DOS angiogram
that utilizes gamma frame data assimilation, the skull contours used in our work presumably
would be applicable to frameless devices, although our preference for optimal treatment
outcomes remains GKRS at our institution.
Conclusions
4D-CTA offers a reliable means of nidus delineation for GKRS planning in AVM treatment.
Performing 4D-CTA prior to the day of treatment offers a significant reduction in frame time.
Preliminary results demonstrate similar times to obliteration among CTA-assisted planning
cases and those using traditional catheter-based angiograms.
Additional Information
Disclosures
Human subjects: Consent was obtained by all participants in this study. West Virginia
University Office of Research Integrity and Compliance issued approval 1408383213. Action
Date 07/17/2017 To Christopher Cifarelli From WVU Office of Research Integrity and
Compliance Approval Date 08/07/2014 Expiration Date 07/16/2018 Subject Acknowledgement
Letter Exempt Initial Protocol Review Protocol Number 1408383213R001 Title The use of 4D
CT Angiography in pre-operative Gamma Knife treatment planning The above-referenced study
was reviewed by the West Virginia University Institutional Review Board IRB and was granted
exemption in accordance with 45 CFR 46.101. • This research study was granted an exemption
in accordance with Research on existing data, documents, records, pathological specimens, or
diagnostic specimens [45 CFR 46.101(4)]. In accordance with the Health Insurance Portability
and Accountability Act, a waiver of research authorization has been granted. Please fulfill the
subject accounting requirements associated with the granting of this waiver. All exemptions are
only good for three years. If this research extends more than three years beyond the approved
date, then the researcher will have to request another exemption. The following documents
have been acknowledged for use in this study and are available in the WVU+kc system:
Documents reviewed and/or approved as part of this submission: HIPAA Waiver
Form_Blank_GK.pdf: 2014-08-03-04:00 4DCTA_AVM_Data Sheet.xlsx: 2014-08-03-04:00
Documents for use in this study have been acknowledged and are available in the WVUkc
system in the Notes and Attachments section of your protocol. The Office of Research Integrity
and Compliance is here to provide assistance to you from the initial submission of an IRB
protocol and all subsequent activity. Please feel free to contact us by phone at 304.293.7073
with any question you may have. Thank you. Animal subjects: All authors have confirmed that
this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with
the ICMJE uniform disclosure form, all authors declare the following: Payment/services info:
All authors have declared that no financial support was received from any organization for the
submitted work. Financial relationships: All authors have declared that they have no
financial relationships at present or within the previous three years with any organizations that
might have an interest in the submitted work. Other relationships: All authors have declared
that there are no other relationships or activities that could appear to have influenced the
submitted work.
2018 Cifarelli et al. Cureus 10(6): e2788. DOI 10.7759/cureus.2788 10 of 12
References
1. Mohr JP, Parides MK, Stapf C, et al.: Medical management with or without interventional
therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-
blinded, randomised trial. Lancet. 2014, 383:614-621. 10.1016/S0140-6736(13)62302-8
2. Pollock BE, Flickinger JC, Lunsford LD, Maitz A, Kondziolka D: Factors associated with
successful arteriovenous malformation radiosurgery. Neurosurgery. 1998, 42:1239-1244.
10.1097/00006123-199806000-00020
3. Ding D, Starke RM, Kano H, et al.: Radiosurgery for cerebral arteriovenous malformations in a
randomized trial of unruptured brain arteriovenous malformations (ARUBA)-eligible patients:
a multicenter study. Stroke. 2016, 47:342-349. 10.1161/STROKEAHA.115.011400
4. Yen CP, Ding D, Cheng CH, Starke RM, Shaffrey M, Sheehan J: Gamma knife surgery for
incidental cerebral arteriovenous malformations. J Neurosurg. 2014, 121:1015-1021.
10.3171/2014.7.JNS131397
5. Dawkins AA, Evans AL, Wattam J, et al.: Complications of cerebral angiography: a prospective
analysis of 2,924 consecutive procedures. Neuroradiology. 2007, 49:753-759. 10.1007/s00234-
007-0252-y
6. Kaufmann TJ, Huston J, 3rd, Mandrekar JN, Schleck CD, Thielen KR, Kallmes DF:
Complications of diagnostic cerebral angiography: evaluation of 19,826 consecutive patients .
Radiology. 2007, 243:812-819. 10.1148/radiol.2433060536
7. Li Q, Lv F, Yao G, Li Y, Xie P: 64-section multidetector CT angiography for evaluation of
intracranial aneurysms: comparison with 3D rotational angiography. Acta Radiol. 2014,
55:840-846. 10.1177/0284185113506138
8. Alnemari A, Mansour TR, Bazerbashi M, Buehler M, Schroeder J, Gaudin D: Dynamic four-
dimensional computed tomography angiography for neurovascular pathologies. World
Neurosurg. 2017, 105:1034-1011. 10.1016/j.wneu.2017.06.022
9. Wang H, Ye X, Gao X, Zhou S, Lin Z: The diagnosis of arteriovenous malformations by 4D-
CTA: a clinical study. J Neuroradiol. 2014, 41:117-123. 10.1016/j.neurad.2013.04.004
10. Lunsford LD, Niranjan A, Kano H, Kondziolka D: The technical evolution of gamma knife
radiosurgery for arteriovenous malformations. Prog Neurol Surg. 2013, 27:22-34.
10.1159/000341625
11. Sadler LR, Jungreis CA, Lunsford LD, Trapanotto MM: Angiographic technique to precede
gamma knife radiosurgery for intracranial arteriovenous malformations. Am J Neuroradiol.
1990, 11:1157-1161.
12. Spiegelmann R, Friedman WA, Bova FJ: Limitations of angiographic target localization in
planning radiosurgical treatment. Neurosurgery. 1992, 30:619-623. 10.1097/00006123-
199204000-00026
13. Bednarz G, Downes B, Werner-Wasik M, Rosenwasser RH: Combining stereotactic
angiography and 3D time-of-flight magnetic resonance angiography in treatment planning
for arteriovenous malformation radiosurgery. Int J Radiat Oncol Biol Phys. 2000, 46:1149-
1154. 10.1016/S0360-3016(99)00530-1
14. Kondziolka D, Lunsford LD, Kanal E, Talagala L: Stereotactic magnetic resonance angiography
for targeting in arteriovenous malformation radiosurgery. Neurosurgery. 1994, 35:585-590.
10.1227/00006123-199410000-00002
15. D'Orazio F, Splendiani A, Gallucci M: 320-Row detector dynamic 4D-CTA for the assessment
of brain and spinal cord vascular shunting malformations. A technical note. Neuroradiol J.
2014, 27:710-717. 10.15274/NRJ-2014-10096
16. Suzuki K, Abe K, Maruyama T, et al.: The role of 4D CT angiography for preoperative
screening in patients with intracranial tumors. Neuroradiol J. 2016, 29:168-173.
10.1177/1971400916638353
17. Kortman HG, Smit EJ, Oei MT, Manniesing R, Prokop M, Meijer FJ: 4D-CTA in neurovascular
disease: a review. Am J Neuroradiol. 2015, 36:1026-1033. 10.3174/ajnr.A4162
18. Willems PW, Brouwer PA, Barfett JJ, terBrugge KG, Krings T: Detection and classification of
cranial dural arteriovenous fistulas using 4D-CT angiography: initial experience. Am J
Neuroradiol. 2011, 32:49-53. 10.3174/ajnr.A2248
19. Hein PA, Romano VC, Lembcke A, May J, Rogalla P: Initial experience with a chest pain
protocol using 320-slice volume MDCT. Eur Radiol. 2009, 19:1148-1155. 10.1007/s00330-008-
1255-8
2018 Cifarelli et al. Cureus 10(6): e2788. DOI 10.7759/cureus.2788 11 of 12
20. Sheth T, Amlani S, Ellins ML, et al.: Computed tomographic coronary angiographic
assessment of high-risk coronary anatomy in patients with suspected coronary artery disease
and intermediate pretest probability. Am Heart J. 2008, 155:918-923.
10.1016/j.ahj.2007.11.035
21. Beijer TR, van Dijk EJ, de Vries J, Vermeer SE, Prokop M, Meijer FJ: 4D-CT angiography
differentiating arteriovenous fistula subtypes. Clin Neurol Neurosurg. 2013, 115:1313-1316.
10.1016/j.clineuro.2012.12.015
22. Shankar JJ, Lum C, Chakraborty S, Dos Santos M: Cerebral vascular malformations: time-
resolved CT angiography compared to DSA. Neuroradiol J. 2015, 28:310-315.
10.1177/1971400915589682
23. Turner RC, Lucke-Wold BP, Josiah D, et al.: Stereotactic radiosurgery planning based on time-
resolved CTA for arteriovenous malformation: a case report and review of the literature. Acta
Neurochir Wien. 2016, 158:1555-1562. 10.1007/s00701-016-2874-5
24. Attia A, Tatter SB, Weller M, et al.: CT-only planning for gamma knife radiosurgery in the
treatment of trigeminal neuralgia: methodology and outcomes from a single institution. J Med
Imaging Radiat Oncol. 2012, 56:490-494. 10.1111/j.1754-9485.2012.02403.x
25. Park KJ, Kano H, Berkowitz O, et al.: Computed tomography-guided gamma knife stereotactic
radiosurgery for trigeminal neuralgia. Acta Neurochir Wien. 2011, 153:1601-1609.
10.1007/s00701-011-1026-1
26. Kamath R, Ryken TC, Meeks SL, Pennington EC, Ritchie J, Buatti JM: Initial clinical
experience with frameless radiosurgery for patients with intracranial metastases. Int J Radiat
Oncol Biol Phys. 2005, 61:1467-1472. 10.1016/j.ijrobp.2004.08.021
27. Minniti G, Scaringi C, Clarke E, Valeriani M, Osti M, Enrici RM: Frameless linac-based
stereotactic radiosurgery (SRS) for brain metastases: analysis of patient repositioning using a
mask fixation system and clinical outcomes. Radiat Oncol. 2011, 6:158. 10.1186/1748-717X-6-
158
28. Franzin A, Panni P, Spatola G, et al.: Results of volume-staged fractionated gamma knife
radiosurgery for large complex arteriovenous malformations: obliteration rates and clinical
outcomes of an evolving treatment paradigm. J Neurosurg . 2016, 125:104-113.
10.3171/2016.7.GKS161549
29. Seymour ZA, Sneed PK, Gupta N, et al.: Volume-staged radiosurgery for large arteriovenous
malformations: an evolving paradigm. J Neurosurg. 2016, 124:163-174.
10.3171/2014.12.JNS141308
30. Anghelescu DL, Burgoyne LL, Liu W, et al.: Safe anesthesia for radiotherapy in pediatric
oncology: St. Jude Children's Research Hospital experience, 2004-2006. Int J Radiat Oncol Biol
Phys. 2008, 71:491-497. 10.1016/j.ijrobp.2007.09.044
2018 Cifarelli et al. Cureus 10(6): e2788. DOI 10.7759/cureus.2788 12 of 12
